L960-1065 Screening compound: 3-{[3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

L960-1065 Screening compound: 3-{[3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-1,2,4-oxadiazole-5-carboxamide
L960-1065 Screening compound: 3-{[3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-1,2,4-oxadiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L960-1065
3-{[3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L960-1065

Molecular Formula

C19H18FN5O4 (C19 H18 FN5 O4)

Compound Name

3-{[3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-1,2,4-oxadiazole-5-carboxamide

IUPAC name

3-{[3-(4-fluorophenyl)-6-oxo-16-dihydropyridazin-1-yl]methyl}-N-[(oxolan-2-yl)methyl]-124-oxadiazole-5-carboxamide

SMILES

O=C(c1nc(CN(C(C=C2)=O)N=C2c(cc2)ccc2F)no1)NCC1OCCC1

InChI

InChI=1S/C19H18FN5O4/c20-13-5-3-12(4-6-13)15-7-8-17(26)25(23-15)11-16-22-19(29-24-16)18(27)21-10-14-2-1-9-28-14/h3-8,14H,1-2,9-11H2,(H,21,27)/t14-/m1/s1

InChI Key

GSUMMKBQDMCRNR-CQSZACIVSA-N

MDL Number (MFCD)

MFCD27490172

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

399.38

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.099

Distribution Coefficient, logD

1.099

Water Solubility, LogSw

-2.17

Polar Surface Area

94.555

Acid Dissociation Constant (pKa)

12.63

Base Dissociation Constant (pKb)

0.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.60

L960-1065 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L960-1065 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L960-1065?
Check Price and Availability of L960-1065, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L960-1065 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L960-1065
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L960-1065
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L960-1065 available by request